$1.04 -0.05 (-4.59%)
11/6/2009 3:59 PM

Aeterna Zentaris, Inc. (USA) (AEZS)

CAPS Rating: 5 out of 5

A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.

Current Price $1.04 Mkt Cap $60.85M
Open $1.11 P/E Ratio 16.62
Prev. Close $1.09 Div. (Yield) N/A (N/A)
Daily Range $1.03 - $1.12 Volume 68,939
52-Wk Range $0.26 - $3.25 Avg. Daily Vol. 396,000

Related News and Articles

Caps

This ticker is not currently Ratable.

Add Stock to Watchlist

All Members

40 Outperform
3 Underperform
 

All-Star Members

8 Outperform
2 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top AEZS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

derwin24 (34.84)
Submitted October 27, 2007

Short term: This stock is probable to Underperform. The Company provided updated guidance for the 2007 total expected burn in a range of $25-$27 million.Long term: This will be a hot stock to own. Potential for base case peak annual sales of over… More

2 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

AEZS VS S&P 500 (SPY)

Fools bullish on AEZS are also bullish on:

Fools bearish on AEZS are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about AEZS.

Recs

0
Member Avatar Brian7992 (< 20) Submitted: 8/11/2009 2:29:09 PM : Outperform Start Price: $2.70 AEZS Score: -69.20

Bio Beautiful

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar EddyG3 (< 20) Submitted: 7/21/2009 9:12:43 AM : Outperform Start Price: $1.78 AEZS Score: -54.51

Expecting positive phase 3 results for Cetrorelix sometime this Q

Report this Post 0 Comments | Reply | Permalink

Recs

2
Member Avatar derwin24 (34.84) Submitted: 10/27/2007 5:12:33 AM : Outperform Start Price: $1.92 AEZS Score: -18.75

Short term: This stock is probable to Underperform. The Company provided updated guidance for the 2007 total expected burn in a range of $25-$27 million.

Long term: This will be a hot stock to own. Potential for base case peak annual sales of over $500 million in the United States market alone; lower sales could reach $200 million.

Report this Post 2 Comments | Reply | Permalink
View All 11 Pitches »

Leaderboard

Find the members with the highest scoring picks in AEZS.

Score Leader

GC39

GC39 (87.40) Score: +65.64

The Score Leader is the member with the highest score across all their picks in AEZS.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. YoungScientist63 83.97 1/19/2007 Underperform 1Y $4.38 -76.26% -20.23% +56.03 1 Comment
Azurepoet 94.99 5/14/2007 Underperform NS $3.64 -71.43% -24.92% +46.51
jazper292 < 20 6/6/2007 Underperform 1Y $3.53 -70.54% -25.51% +45.03
derwin24 34.84 10/29/2007 11/2/2007 Outperform 1Y $1.92 -45.83% -27.08% -18.75 3 Comments
MoeMoneyforMr2 < 20 10/30/2007 Outperform 3M $1.95 -46.67% -26.85% -19.81
kevrose31 67.68 11/7/2007 Outperform 5Y $1.96 -46.94% -25.39% -21.54
kerwin8 48.20 11/6/2007 Outperform 1Y $1.98 -47.47% -25.60% -21.87
bankaininja < 20 10/9/2007 Outperform NS $2.33 -55.36% -27.87% -27.50
valuewins < 20 12/28/2006 Outperform 1Y $2.48 -58.12% -20.15% -37.96
Zentaur 28.51 8/24/2007 Outperform 5Y $2.84 -63.38% -23.01% -40.37
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackRBCCapMkts 81.74 8/15/2007 Outperform NS $2.48 -58.06% -20.78% -37.29
TrackOppenheimer 26.63 5/15/2007 Outperform NS $3.58 -70.95% -24.84% -46.11
TrackRodmanRen < 20 5/9/2007 Outperform NS $3.68 -71.74% -24.90% -46.83
TrackJanney 78.51 12/28/2006 Outperform NS $2.48 -58.12% -20.15% -37.96
TrackCanaccord 84.17 9/18/2006 Outperform NS $3.05 -65.96% -13.71% -52.25

Featured Broker Partners